Your session is about to expire
← Back to Search
Psychosocial therapy for cannabis use disorder. for Cannabis Use Disorder
Study Summary
This trial is investigating a new treatment for cannabis use disorder that targets implicit reward-driven processes. The study is a four-session randomized, double-blind, sham-controlled pilot treatment trial. One-hundred and six (106) treatment-seeking adults with moderate to severe CUD will be recruited, with an equal number of men and women. The study will test whether the treatment reduces cannabis cue-reactivity and cannabis use.
- Cannabis Use Disorder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are currently taking medication for mental health that may interfere with the study's results (except for antidepressants).You are currently thinking about hurting yourself. If you are having these thoughts, you will be referred to a specialist for help.You have a serious medical or neurological condition that can affect your ability to think and process information.You primarily use cannabis as your drug of choice.You must not drink alcohol or use cannabis for at least 12 hours before study visits. You must also avoid other drugs of abuse (except nicotine) for three days before the visit.You have a history of or currently have a severe mental health disorder such as bipolar disorder, ADHD, untreated major depression or psychosis which may impact the study's ability to measure subjective outcomes.
- Group 1: Active ABM + CBT/MET
- Group 2: Sham ABM + CBT/MET
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the trial accepting new participants at this time?
"The clinicaltrials.gov database indicates that this trial is actively enrolling patients, with the initial posting made on November 5th 2018 and subsequent edits taking place as recently as November 28th 2022."
To what extent is this clinical experiment being participated in?
"Correct. The clinicaltrials.gov website reveals that this medical study, which was first posted on November 5th 2018, is actively recruiting patients. Approximately 106 individuals must be recruited from a single site."
Does the criteria for this clinical trial allow individuals below 65 years of age to participate?
"To be considered for this trial, the patient must fall in the 18-65 age range. For those under or over that threshold, there are 15 and 48 alternative clinical trials respectively."
Who is considered to be the ideal candidate for this clinical experiment?
"This clinical trial seeks 106 participants with a history of hashish abuse, between the ages 18 and 65. Crucially, volunteers must agree to remain abstinent from alcohol for 12 hours prior to study visits and other drugs (except nicotine) for 72 hours before their participation in this research. This is necessary so that all data collected may be free from any influence caused by recent substance use."
Share this study with friends
Copy Link
Messenger